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changes in hemodynamics 
associated with metabolic 
syndrome are more pronounced in 
women than in men
pauliina Kangas  1*, Antti tikkakoski1,2, Jarkko Kettunen1, Arttu eräranta1, Heini Huhtala  3, 
Mika Kähönen1,2, Kalle Sipilä2, Jukka Mustonen1,4 & ilkka pörsti1,4
the increase in cardiovascular risk associated with metabolic syndrome (MS) seems higher in women 
than in men. We examined hemodynamics during head-up tilt in 252 men and 250 women without 
atherosclerosis, diabetes, or antihypertensive medication, mean age 48 years, using whole-body 
impedance cardiography and radial pulse wave analysis. MS was defined according to Alberti et al. 
2009. Men and women with MS presented with corresponding elevations of systolic and diastolic blood 
pressure (10-14%, p ≤ 0.001) versus controls. Supine pulse wave velocity (16–17%, p < 0.001) and 
systemic vascular resistance (7–9%, p ≤ 0.026), and upright cardiac output (6–11%, p ≤ 0.008) were 
higher in both MS groups than controls. Elevation of supine aortic characteristic impedance was higher 
in women than in men with MS (16% vs. 8%, p = 0.026), and in contrast to men, no upright impedance 
reduction was observed in women. When upright, women but not men with MS showed faster return 
of reflected pressure wave (p = 0.036), and smaller decrease in left cardiac work (p = 0.035) versus 
controls. The faster upright return of reflected pressure, lower upright decrease in left cardiac work, and 
higher elevation of aortic characteristic impedance may contribute to the greater increase in MS-related 
cardiovascular risk in women than in men.
Metabolic syndrome (MS) is defined as a cluster of abnormalities in glucose tolerance, lipid profile, blood pres-
sure (BP), and amount of visceral adipose tissue1. When compared with subjects without MS, a 5-fold increase in 
the risk of type 2 diabetes mellitus, and a 2-fold risk of developing cardiovascular (CV) disease over the next 5–10 
years, is observed in subjects with MS1. Due to the increasing incidence of overweight, the prevalence of MS has 
strongly increased over the last decades2.
The mechanisms underlying the elevated CV risk in MS have been under active investigation, and several 
studies have addressed the associated hemodynamic alterations. Increased large arterial stiffness3, aortic pulse 
pressure4, and systemic vascular resistance (SVR) have been associated with MS5. Also decreased left ventricu-
lar stroke index, and impaired left ventricular systolic and diastolic functions have been found in individuals 
with MS5,6. Obesity and MS are also associated with arrhythmias7–9, and increased arrhythmic burden is not 
only observed in MS patients with a failing heart but even in subjects with normal cardiac morphology10,11. 
When compared with subjects without MS, the prevalence of left ventricular hypertrophy12, and even the risk of 
CV mortality13, are more pronounced in women than in men with MS. Furthermore, the predisposing effect of 
MS on early atherosclerosis is higher in women than in men14. The underlying mechanisms are not completely 
understood.
Recently, we found that a clear difference in cardiovascular responses between sexes was higher workload for 
the heart in men in the upright position, a finding that was not explained by known cardiovascular risk factors 
or hormonal differences15. To our knowledge, the regulation of upright hemodynamics has not been examined 
in subjects with MS. In the present study, our objective was to examine whether there are differences in the 
MS-associated changes in cardiovascular function between men and women. To test this hypothesis, non-invasive 
1Faculty of Medicine and Health Technology, FI-33014 Tampere University, Tampere, Finland. 2Department of Clinical 
Physiology and Nuclear Medicine, Tampere University Hospital, P.O. Box 2000, FI-33521, Tampere, Finland. 3Faculty 
of Social Sciences, FI-33014 Tampere University, Tampere, Finland. 4Department of Internal Medicine, Tampere 
University Hospital, P.O. Box 2000, FI-33521, Tampere, Finland. *email: pauliina.kangas@fimnet.fi
open
2Scientific RepoRtS |         (2019) 9:18377  | https://doi.org/10.1038/s41598-019-54926-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
hemodynamics were recorded in supine position and during passive head-up tilt in men and women with MS and 
respective controls groups.
Methods
Study subjects. This study is part of an ongoing clinical study on hemodynamics in the University of Tampere 
(DYNAMIC-study, clinical trial registration NCT01742702). The participants gave written informed consent, and 
the study was approved by the Ethics Committee of Tampere University Hospital (study code R06086M) conform-
ing to the principles outlined in the Declaration of Helsinki. The participants were enrolled from adult patients (age 
≥18 years) treated at Tampere University Hospital, and enrollment was also made via announcements in offices of 
local occupational health care providers, Varala Sports Institute, among employees of the Tampere University and 
Tampere University Hospital, while 2 announcements were published in local newspapers. Those who agreed to 
participate were recruited in the order in which their contact information was available to the research nurses. The 
present population was screened from 956 volunteers. The exclusion criteria were diagnosed diabetes, atheroscle-
rosis, cardiac insufficiency, cerebrovascular disease, heart rhythm other than sinus; any acute health problem; and 
use of antihypertensive drugs or other medications with influences on hemodynamics (α1-adrenoceptor blockers 
for prostate problems, β-blocker eye drops for glaucoma, β2-adrenoceptor agonists, and digoxin). The study group 
consisted of 502 subjects aged 24–72 years (mean 48, SD 9.3). Lifestyle habits, family history, medical history, and 
use of medicines were recorded, and clinical cardiovascular status was examined. Laboratory tests were taken 
11 ± 2 days (mean ± 95% confidence interval (CI) of the mean) before the hemodynamic recordings in order to 
exclude concurrent illnesses that would interfere with the interpretation of the results.
MS was defined according to Alberti et al.1, so that ≥3 of the following criteria were met: waist circumfer-
ence ≥94 cm (men) and ≥80 cm (women); triglycerides ≥1.7 mmol/l; high density lipoprotein (HDL) choles-
terol <1.0 mmol/l (men) and <1.3 mmol/l (women); systolic BP ≥130 mmHg and/or diastolic BP ≥85 mmHg; 
fasting plasma glucose ≥5.6 mmol/l1. The subjects were allocated to 4 groups: men without MS (Men-control, 
n = 133), men with MS (Men-MS, n = 119), women without MS (Women-control, n = 196), and women with MS 
(Women-MS, n = 54).
Altogether 181 subjects (36% of the study population) used medications (Table 1). Thirteen were on statins for 
dyslipidemia, 75 female subjects (30%) used systemic estrogen, progestin, or their combination (contraception or 
hormone replacement therapy), and one subject used tibolone. There was no difference in the use of female hor-
mones between the Women-control and Women-MS groups (p = 0.990). One subject without symptoms used war-
farin for anti-phospholipid syndrome. Also other medications (acetylsalicylic acid, selective serotonin re-uptake 
inhibitors, antihistamines, thyroid hormones, proton pump inhibitors, and intranasal or inhaled corticosteroids) 
were  used by individual subjects (see Table 1). Information about alcohol intake was missing from 13 subjects.
Hemodynamic measurements. The subjects were advised to refrain from caffeine containing products, 
smoking and heavy meals for ≥4 hours, and from alcohol for ≥24 hours prior to the recordings15,16. The record-
ings took place between 08:30 a.m. and 04:00 p.m. on working days. A brief introductory passive head-up tilt 
on a tilt-table was performed with ≥5 minutes of rest in the supine position before and after the head-up tilt. 
Then hemodynamics were recorded by a trained research nurse in a temperature-controlled laboratory during 
two consecutive 5-minute periods with continuous capture of data: 5 minutes supine on a tilt table, followed by 
passive head-up tilt to ≥60 degrees for 5 minutes15–17. For the definition of MS, the average systolic and diastolic 
BPs of the last supine 3 minutes were used. The detailed description of the protocol has been published15–17, and 
the repeatability and reproducibility of the measurements has been demonstrated (repeatability index in two 
consecutive measurements for augmentation index (AIx) 95% supine and 95% upright, for stroke volume 99% 
supine and 99% upright; reproducibility index on four separate days for AIx 78% supine and 70% upright, for 
stroke volume 89% supine and 93% upright)17.
pulse wave analysis, pWA. BP and pulse wave form were continuously captured from the radial pulsation 
by a tonometric sensor (Colin BP-508T, Colin Medical Instruments Corp., USA). Radial BP signal was calibrated 
approximately every 2.5 minutes by contralateral brachial BP measurements. Variables of central pressures and 
wave reflection (forward wave amplitude, subendocardial viability ratio (SEVR, ratio of diastolic area/min to 
systolic area/min); aortic BP, reflection time, AIx, and AIx related to heart rate 75/min (AIx@75)) were derived 
online using a pulse wave monitoring system (SphygmoCor PWMx, AtCor medical, Australia), and a previously 
validated generalized transfer function18. The left arm with the tonometric sensor was abducted to 90 degrees in a 
support, which held the arm and the wrist steady at the level of the heart in both supine and upright positions15,16.
Whole-body impedance cardiography. Whole-body impedance cardiography (CircMonR, JR Medical 
Ltd., Tallinn, Estonia), was used to determine beat-to-beat heart rate, cardiac output and aortic-to-popliteal pulse 
wave velocity (PWV)19,20. SVR and left cardiac work (LCW) were calculated from the tonometric BP and cardiac 
output measured by the CircMonR. Average supine central venous pressure is ~3–4 mmHg, while during upright 
position the value is close to zero mmHg21–23. As central venous pressure was not measured in the present study, 
the formula for SVR estimation did not include this variable and was calculated as follows: SVR = 79.96 * mean 
arterial BP/cardiac output; 79.96 was the conversion factor from mmHg/L/min to dyn*s/cm5. LCW was calcu-
lated as 0.0143 × (mean arterial BP − pulmonary artery occlusion pressure) × cardiac output. Pulmonary artery 
occlusion pressure was assumed to be 6 mmHg (normal), and 0.0143 was the conversion factor of pressure from 
millimeter of mercury to centimeters of water, volume to density of blood, centimeters to meters, and conversion 
from gram to gram force16. Time-domain estimate of aortic characteristic impedance [(pressure at inflection point 
- diastolic aortic BP) * systolic time)/(stroke volume * 2)] was calculated according to Chemla et al. so that aortic 
BP and systolic time were derived from pulse wave analysis and stroke volume from impedance cardiography24.
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When using the CircMonR whole body impedance cardiography, the cardiac output values of correlate well 
with the thermodilution method (bias 0.00 l/min, 95% CI −0.26 to 0.26) and the direct oxygen Fick method (bias 
−0.32 l/min, 95% CI −0.69 to 0.05)25, corresponding upright reductions in cardiac output are observed when 
compared with thermodilution21, the upright stroke volume shows good correlation with 3-dimensional echo-
cardiography (r = 0.781, bias 4.1 ml, 95% CI −2.2 to 10.4)16, and the PWV values show good correlation with the 
Men-control 
n = 133
Men-MS 
n = 119
Women-
control n = 196
Women-MS 
n = 54
Acetylsalicylic acid 2 (1.5%) 2 (1.7%) 1 (0.5%) 2 (3.7%)
Acyclovir 1 (0.8%) 0 0 0
Alendronate 0 0 1 (0.5%) 0
Allopurinol 0 1 (0.8%) 0 1 (1.9%)
Amitriptyline 0 0 2 (1.0%) 0
Amoxicillin 0 0 0 1 (1.9%)
Antidepressant (SSRI or SNRI) 3 (2.3%) 5 (4.2%) 11 (5.6%) 6 (11.1%)
Antihistamine 0 2 (1.7%) 8 (4.1%) 1 (1.9%)
Benzodiazepine 0 0 2 (1.0%) 0
Carbamazepine 0 0 0 1 (1.9%)
Carbimazole 0 0 1 (0.5%) 0
Cholestyramine 0 1 (0.8%) 0 0
Dehydroepiandrosterone 1 (0.8%) 0 0 0
Doxycycline (low dose) 0 1 (0.8%) 0 0
Ezetimibe 0 1 (0.8%) 0 0
Female hormones
  Systemic (including tibolone and 
levonorgestrel via intrauterine device) 0 0 59 (30.1%) 16 (29.6%)
  Topical 4 (2.0%) 1 (1.9%)
Glucosamine 2 (1.5%) 1 (0.8%) 2 (1.0%) 1 (1.9%)
Hydroxocobalamin 1 (0.8%) 0 0 0
Hydroxycarbamide 1 (0.8%) 0 0 0
Intranasal or inhaled corticosteroid 1 (0.8%) 3 (2.5%) 9 (4.6%) 1 (1.9%)
Isotretinoin 0 0 1 (0.5%) 0
Letrozole 0 0 1 (0.5%) 0
Levetiracetam 0 0 1 (0.5%) 0
Liothyronine 0 0 0 1 (1.9%)
Mefloquine 0 0 1 (0.5%) 0
Melatonin 1 (0.8%) 0 0 1 (1.9%)
Mepacrine 0 1 (0.8%) 0 0
Mesalazine 0 0 0 1 (1.9%)
Methenamine hippurate 0 0 1 (0.5%) 0
Montelukast 0 0 1 (0.5%) 0
Non-steroidal anti-inflammatory drug 1 (0.8%) 1 (0.8%) 3 (1.5%) 1 (1.9%)
Oxcarbazepine 0 0 1 (0.5%) 0
Pramipexole 0 0 1 (0.5%) 0
Prednisolone 1 (0.8%) 0 0 0
Pregabalin 1 (0.8%) 0 0 1 (1.9%)
Proton pump inhibitor 5 (3.8%) 5 (4.2%) 0 3 (5.6%)
Quetiapine 0 0 1 (0.5%) 0
Statin 5 (3.8%) 5 (4.2%) 0 3 (5.6%)
Tafluprost 0 0 0 1 (1.9%)
Tamoxifen 0 0 1 (0.5%) 0
Thyroxine 1 (0.8%) 0 13 (6.6%) 2 (3.7%)
Valproate 0 0 1 (0.5%) 0
Varenicline 0 0 1 (0.5%) 1 (1.9%)
Vitamin D supplementation 12 (9.0%) 5 (4.2%) 18 (9.2%) 8 (14.8%)
Warfarin 0 1 (0.8%) 0 0
Table 1. Medications used regularly by the study participants (number of participants and percentages with 
each type of medication). SNRI indicates serotonin-norepinephrine reuptake inhibitor; SSRI, selective serotonin 
reuptake inhibitor.
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tonometric method (r = 0.82, bias 0.02 m/s, 95% CI −0.21 to 0.25)20. Due to technical problems, PWV from one 
subject, aortic characteristic impedance and AIx@75 from 3 subjects supine and 3 subjects upright, time to the 
return of the reflected wave from 3 subjects supine and 4 subjects upright, were missing.
Laboratory tests. Fasting plasma glucose, triglycerides, total cholesterol, HDL and low-density lipo-
protein (LDL) cholesterol, and creatinine were measured using Cobas Integra 700/800 or Cobas 6000 (Roche 
Diagnostics, Basel, Switzerland), and insulin using electrochemiluminescence immunoassay (Cobas e 411, Roche 
Diagnostics). Quantitative insulin sensitivity check index (QUICKI) was calculated26. Estimated glomerulus fil-
tration rate (eGFR) was determined using the CKD-EPI formula27. A standard 12-lead electrocardiogram (ECG) 
was recorded and Cornell voltage QRS duration product calculated28. LDL cholesterol values from six subjects, 
and ECG from one subject, were missing.
Statistical analyses. The characteristics between the control and MS groups in each sex (Table 2), and the 
hemodynamic profiles of the MS groups, were compared using independent samples t-test. The skewed triglycer-
ide distribution was logarithmically transformed before the analyses. Alcohol intake, smoking habits, and use of 
female hormones were compared using Mann-Whitney U-test and Pearson Chi-Square test.
Mean values of the hemodynamic variables during each minute of recording in individual study subjects were 
calculated, and the generalized estimating equation (GEE) adjusted for age was applied. This method enabled the 
analyses of repeated measurements over the 10 min recording period to examine the influences of MS, sex, and 
their interaction with posture on the hemodynamic variable of interest. Linear scale response was applied, and 
the autoregressive option was chosen for the correlation matrix, as successive serial measures of hemodynamics 
in individual participants are auto-correlated.
In order to compare the hemodynamic profiles in men and women with MS, the average values of the last 
3 minutes of the supine and upright periods were used due to the representative and stable signal during this 
period29 (please see also figures). In each participant with MS, the mean value of the last 3 minutes of supine or 
upright recording for each variable was calculated as percentage of the respective mean value in the whole corre-
sponding control group (control men or control women). Then the percentage values between men and women 
with MS were compared.
Variable Men-control Men-MS
Women-
control Women-MS
Number of subjects 133 119 196 54
Age (years) 48 ± 10 49 ± 9 47 ± 9 50 ± 10*
BMI (kg/m2) 26 ± 3 30 ± 3* 25 ± 4 30 ± 5*
Weight (kg) 86 ± 12 95 ± 11* 70 ± 13 81 ± 14*
Height (cm) 181 ± 6 179 ± 5* 166 ± 6 165 ± 5
Waist circumference (cm) 95 ± 9 105 ± 8* 85 ± 12 96 ± 12*
Systolic blood pressure (mmHg) 129 ± 15 144 ± 16* 124 ± 18 141 ± 18*
Diastolic blood pressure (mmHg) 74 ± 10 84 ± 10* 72 ± 12 80 ± 12*
Pulse wave velocity (m/s) 8.50 ± 1.8# 9.88 ± 2.0* 7.87 ± 1.4 9.21 ± 1.9*
Stroke volume supine (ml) 99 ± 15 97 ± 11 81 ± 15 77 ± 14
Stroke volume upright (ml) 76 ± 10 78 ± 9 56 ± 8 59 ± 9
Smoking status
Never smoked (n/%) 70/52% 57/48% 123/63% 29/54%
Current smoker (n/%) 21/16% 14/12% 24/12% 6/11%
Previous smoker (n/%) 42/32% 48/40% 49/25% 19/35%
Alcohol intake (standard doses/week) 4 (1–9) 4 (1–10) 2 (1–3) 2 (1–4)
Creatinine (µmol/l) 83 ± 12 81 ± 11 66 ± 9 62 ± 9*
eGFR (ml/min/1.73 m2) 95 ± 13 95 ± 12 95 ± 13 98 ± 13
Fasting plasma glucose (mmol/l) 5.4 ± 0.4 5.9 ± 0.4* 5.2 ± 0.4 5.8 ± 0.5*
Total cholesterol (mmol/l) 5.1 ± 0.9 5.7 ± 1.1* 5.1 ± 1.0 5.7 ± 0.8*
Triglycerides (mmol/l) 1.0 (0.7–1.4) 1.8 (1.1–2.4)* 0.9 (0.6–1.1) 1.5 (1.1–2.1)*
High-density lipoprotein cholesterol (mmol/l) 1.5 ± 0.3 1.2 ± 0.3* 1.9 ± 0.4 1.5 ± 0.4*
Low-density lipoprotein cholesterol (mmol/l) 3.1 ± 0.9 3.7 ± 0.9* 2.8 ± 0.9 3.5 ± 0.7*
Quantitative insulin sensitivity check index 0.365 ± 0.045 0.342 ± 0.040* 0.373 ± 0.041 0.338 ± 0.031*
Cornell voltage product in ECG (ms*mm) 1621 ± 817 1772 ± 557 1546 ± 516 1764 ± 518*
Table 2. Clinical and metabolic characteristics in the study groups. Values are means ± SD except the values 
for smoking, which are the number of cases and percentages, and the values for triglycerides and alcohol intake, 
which are shown as medians (lower and upper quartiles) due to skewed distribution. Men-control, men without 
MS; Men-MS, men with MS; Women-control, women without MS; Women-MS, women with MS; *p < 0.05 MS 
vs control group; BMI, body mass index; eGFR, estimated glomerulus filtration rate27; #n = 132 for pulse wave 
velocity in the Men-control group.
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The results in Table 2 are reported as means and standard deviations (normally distributed variables), medians 
and lower and upper quartiles (variables with skewed distribution), or numbers of cases and percentages (cat-
egorical variables). The figures are depicted as means and 95% CI for the mean. All testing was two-sided, and 
p-values < 0.05 were considered significant. All data were analyzed using IBM SPSS Statistics, software version 
25 (Armonk, New York, USA).
Results
Study population. Mean age did not differ between the Men-control and the Men-MS groups (p = 0.254), 
but was 3 years higher in the Women-MS than in the Women-control group (p = 0.035) (Table 2). BMI, waist 
circumference, and BP were higher in both MS groups than in the control groups (p < 0.001 for all). Aortic-
to-femoral PWV was about 16–17% higher in men and women with MS than in the respective control groups 
without MS (p < 0.001 for all) (Table 2). Smoking and alcohol use did not differ between the MS and the control 
groups (p > 0.1 for all).
The eGFR value did not differ between the MS and the respective control groups (p > 0.21 for men and 
women). As expected, fasting plasma glucose, total and LDL cholesterol, and triglycerides were higher, while 
HDL cholesterol and QUICKI were lower, in subjects with MS than in subjects without MS (p < 0.001 for all). In 
women with MS, Cornell voltage product was higher than in women without MS (p = 0.007), while in men the 
difference between the groups was not significant (p = 0.092).
Hemodynamics in MS versus control groups. During the 10-minute recording protocol (5 minutes 
supine, 5 minutes of head-up tilt) radial systolic and diastolic BP (Fig. 1a,b), heart rate (Fig. 1c), SVR (Fig. 1d), 
cardiac output (Fig. 1e), LCW (Fig. 2a), aortic pulse pressure (Fig. 2b), aortic characteristic impedance (Fig. 2c), 
and AIx@75 (Fig. 2f) were higher in men and women with MS than in the respective control groups. However, 
cardiac output values related to body surface area (cardiac index) did not differ between the MS groups and the 
respective control groups (Fig. 1f). The time to the return of the reflected wave was shorter (Fig. 2d) and SEVR 
was lower (Fig. 2e) in both MS groups than in the respective control groups.
Hemodynamics and sex. All of the hemodynamic variables were different between sexes. Radial systolic 
and diastolic BP (Fig. 1a,b), cardiac output (Fig. 1e), cardiac index (Fig. 1f), LCW (Fig. 2a), and SEVR (Fig. 2e) 
were lower, while aortic reflection time was shorter (Fig. 2d) in women than in men. In contrast, heart rate 
(Fig. 1c), SVR (Fig. 1d), aortic pulse pressure (Fig. 2b), aortic characteristic impedance (Fig. 2c), and AIx@75 
(Fig. 2f) were higher in women than in men.
Hemodynamics and posture, interactions between posture and sex. With the exception of aor-
tic characteristic impedance in women, all of the hemodynamic variables changed significantly in response to 
head-up tilting from supine to upright posture (Figs. 1, 2, p < 0.001 for changes in all variables, p-values not 
shown in figures). Supine and upright stroke volumes are presented in Table 2.
A significant interaction between sex and posture was observed in some variables. In response to the change 
from supine to upright position, women presented with higher increase in SVR (Fig. 1d); more pronounced 
decreases in cardiac output, cardiac index and LCW (Figs. 1e,f, 2a); and no decrease in aortic characteristic 
impedance (Fig. 2c) when compared with men (p < 0.001 for all, p-values not shown in figures). In men the eval-
uated aortic characteristic impedance was significantly reduced in the upright position when compared with the 
supine values (p < 0.001).
interactions between metabolic syndrome, posture and sex. A significant interaction between the 
MS, posture and sex was observed in the following variables: women with MS presented with increased supine 
heart rate, SVR, and aortic characteristic impedance (Figs. 1c,d, 2c); increased upright cardiac output, cardiac 
index and LCW (Figs. 1e,f, 2a), and shortened upright aortic reflection time (Fig. 2d). Of note, in men none of 
the changes of the hemodynamic variables in response to upright posture differed between the Men-MS and 
Men-control groups.
Profiles of the MS-related hemodynamic changes in men and women. In both sexes MS was char-
acterized by 10-14% higher supine and upright systolic and diastolic BP (Table 2, Fig. 1) than in the respective 
control groups.
Although MS was associated with a similar rise in PWV (a variable that was only recorded in the supine 
position) in women and men (16.6 ± 5.5% vs. 16.1 ± 3.5%, respectively, p = 0.873, Fig. 3), supine aortic charac-
teristic impedance was more increased in women than in men with MS (16.0 ± 6.0% vs. 7.5 ± 3.9%, respectively, 
Fig. 3, p = 0.026). The supine percent changes in the other hemodynamic variables were not significantly different 
between the Men-MS and Women-MS groups (Fig. 3).
The upright increase in LCW (18% vs. 26%, p = 0.035) and decrease in aortic reflection time (0.6% vs. 3.0%, 
p = 0.036) were more pronounced in women than in men with MS (Fig. 3). The percent changes in the other 
hemodynamic variables in the upright position were not significantly different between men and women with MS.
Discussion
In this study we evaluated hemodynamic changes associated with MS in 502 subjects. We found corresponding 
increases in PWV, and supine and upright BP in men and women with MS. Still, higher increase in the evaluated 
supine aortic characteristic impedance was observed in women with MS. During the head-up tilt, women with 
MS presented with shortened time to the return of the reflected wave and higher increase in LCW than men with 
MS. The GEE-analyses also uncovered significant interactions between MS and female sex in the upright cardiac 
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output and LCW, indicating more pronounced changes in these variables than in men with MS. Altogether, com-
parable MS-related increases in BP and large arterial stiffness were associated with hemodynamic changes that 
potentially burden the heart more in women. Of note, in contrast to men, aortic characteristic impedance was not 
decreased in the upright position in women. The present results suggest that increases in both SVR and cardiac 
output contribute to the elevation of BP in MS.
The MS-associated increase in CV risk appears to be higher in women than in men12,13, while MS adversely 
influences cardiovascular morbidity in subjects with primary hypertension independent of its individual compo-
nents30. The pathophysiology of the hemodynamic changes in MS is not completely clear, but an important factor 
is increased large artery stiffness3,31. In the present study PWV was 16–17% higher in men and women with MS 
than in the control subjects.
In the proximal aorta characteristic impedance regulates the relationship between pressure and flow24,32. These 
variables are also influenced by aortic reservoir characteristics33–36, although the matter remains controversial37,38. 
Stiffening of the aorta increases the impedance to flow, while aortic impedance is more sensitive to changes in 
Figure 1. Blood pressure (BP) and variables defining BP level: radial systolic BP (a), radial diastolic BP (b), 
heart rate (c), systemic vascular resistance (SVR) (d), cardiac output (e), and cardiac index (f); means and 
95% confidence intervals of the mean for each minute of recording; age-adjusted p-values calculated using 
general estimating equations; significant interactions between posture, metabolic syndrome (MS), and sex 
(Posture*MS*Sex) shown by green symbol color; n = 133 in men without metabolic syndrome (MS), n = 119 in 
men with MS; n = 196 in women without MS, n = 54 in women with MS.
7Scientific RepoRtS |         (2019) 9:18377  | https://doi.org/10.1038/s41598-019-54926-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
vessel radius than PWV24. In the present study, the increase in supine aortic characteristic impedance was higher 
in women than in men with MS (16.0% vs. 7.5%, respectively). As the diameter and length of the large arteries are 
lesser in women than in men39, these findings may be attributed to the influences of arterial stiffening upon the 
smaller aortic size of women. Previously, aortic characteristic impedance and AIx were higher, and time to the 
return of the reflected wave was shorter, in elderly 272 women than in 189 men40.
AIx is higher in women than in men due to shorter stature and smaller large artery size41–44. The AIx as 
a parameter of wave reflection is influenced by ejection time, heart rate, arterial diameter, wall elasticity, wall 
thickness, arterial branching, and resistance to flow in small arteries39. In the present study, AIx was higher, and 
the time to the return of the reflected pressure wave was shorter, in women than in men both supine and upright. 
In contrast to men, aortic characteristic impedance was not reduced in the upright position in women. Previous 
results indicate that SVR may not directly affect wave reflection but rather via changes in BP that have a secondary 
influence on stiffness, and that blood vessel geometry has a more important role in wave reflection than SVR45. 
Figure 2. Variables related to cardiac workload and wave reflection: left cardiac work (LCW) (a), aortic pulse 
pressure (b), aortic characteristic impedance (c), time to return of the reflected wave (d), subendocardial 
viability ratio (SEVR) (e), and augmentation index related to heart rate 75/min (f); means and 95% confidence 
intervals of the mean for each minute of recording; age-adjusted p-values calculated using general estimating 
equations; significant interactions between posture, metabolic syndrome (MS), and sex (Posture*MS*Sex) shown 
by green symbol color; n = 132–133 in men without metabolic syndrome (MS), n = 118–119 in men with MS; 
n = 196 in women without MS, n = 51–54 in women with MS.
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However, higher supine SVR and more pronounced upright increase in SVR may contribute to higher wave 
reflections in women.
MS is associated with increased left ventricular mass and impaired systolic and diastolic function6,46. Women 
with MS may be more susceptible to these changes than men12,47, possibly due to the higher aortic characteristic 
impedance40. In 2945 subjects, increased aortic characteristic impedance was associated with worse left ventricu-
lar global longitudinal strain, however in adjusted analyses this relation was only observed in women48. In the 
present study, supine LCW was increased by 16% in both sexes with MS, but in the upright position the increase 
in LCW was higher in women than in men (27% vs. 18%, respectively). In addition, supine (−4% vs. −9%, 
p = 0.085) and upright (−4% vs. −7%, p = 0.120) decreases in SEVR, a variable evaluating myocardial oxygen 
supply versus demand49, were numerically higher in women than in men with MS. When compared with respec-
tive control groups, Cornell voltage product was also higher in women but not in men with MS. Previously, lower 
Figure 3. Bar graphs show percent differences in pulse wave velocity (PWV), systemic vascular resistance 
(SVR), cardiac output (CO), left cardiac work (LCW), aortic pulse pressure (AO PP), aortic characteristic 
impedance (AO IMPED), aortic reflection time (AO RT), and subendocardial viability ratio (SEVR) in the MS 
groups versus respective controls, p-values adjusted for age. In each participant with MS, the mean value of the 
last 3 minutes of supine or upright period of each variable was calculated as percentage of the respective mean 
value in the whole corresponding control group of participants.
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SEVR was attributed to lower diastolic pressure-time integral and shorter diastole in female than male subjects 
aged 2–81 years44. Not surprisingly, increased arrhythmic burden has been reported in patients with MS10,11. 
Serum analysis of biomarkers like B-type natriuretic peptide and troponin-I can be used to predict clinical out-
comes in patients with MS who suffer from cardiac failure50.
Sympathetic overdrive has been linked with MS, and autonomic imbalance may contribute to the increased 
CO, SVR and BP in subjects with MS51,52. The changes in autonomic tone related to MS may also be more pro-
nounced in women than in men52–55. Of note, the alterations in autonomic tone in subjects who are overweight, 
a characteristic feature of MS, show remarkable disparity56. Overweight subjects may have normal cardiac 
sympathetic activity and neuronal noradrenaline uptake, while afferent renal sympathetic activity may still be 
increased56. Decreased parasympathetic activity is also a putative cause for an imbalance in autonomic func-
tion57,58. We recently found that reduced total and high frequency power of heart rate variability in the upright 
position may partially explain why the relative increase in cardiovascular risk associated with MS is greater in 
women than in men53. Further studies on the sex-related differences of autonomic tone in MS are warranted.
Different levels of sex hormones and putative changes in the sex hormone profiles are prime candidates for the 
hemodynamic differences between men and women with MS. In men, MS is associated with reduced testosterone 
levels59, while in women the situation is reversed and testosterone levels are increased in subjects with MS60. The 
sex-related differences in testosterone metabolism potentially influence the hemodynamic responses in men and 
women with MS, and make an interesting subject for future investigations.
Our study has limitations. (1) The observational design does not allow conclusions about causal relation-
ship. (2) The age differences among the study population comprising 252 men and 250 women were rather 
large. (3) The non-invasive measurements required mathematical processing and simplification of physiology25. 
Pulmonary artery occlusion pressure was not measured and was assumed to be normal. Supine central venous 
pressure is normally about 3–4 mmHg, while the upright value is close to zero mmHg21–23. As this variable was 
not measured either, central venous pressure was not included in the formula to calculate SVR. (4) The formula 
for the estimation of aortic impedance may be more suitable for invasive measurements than tonometric record-
ings24. (5) Although subjects using medications with direct influences on hemodynamics were excluded, the 
other medications used by 36% of the study population may have influenced the results. Importantly, the use of 
female hormones did not differ between women with and without MS (Table 1). (6) Information about the phase 
of the menstrual cycle in the female subjects was not available. (7) The criteria of Alberti et al. were applied for the 
definition of MS1, instead of the definition by National Cholesterol Education Program61. With the Alberti et al. 
criteria, healthier subjects are defined to have MS. Despite this, the results showed clear hemodynamic changes 
associated with MS.
In summary, men and women with MS had higher BP than the control subjects without MS. This was prob-
ably explained by higher SVR, higher cardiac output, and higher arterial stiffness in subjects with MS. Several of 
the MS-related changes in hemodynamics seemed more pronounced in women than in men. When compared 
with the MS-related findings in men, women with MS presented with smaller decreases in cardiac output and 
LCW in the upright position than women without MS, and shortened time to the return of the reflected pressure 
wave. Women with MS had also a more pronounced increase in aortic characteristic impedance for a similar 
increase in BP and arterial stiffness than men with MS. These changes that influence the workload to the heart 
may contribute to the higher increase in CV risk associated with MS in women.
Data availability
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